CLOs on the Move

Institute For Safe Medication Practices

www.ismp.org

 
Institute For Safe Medication Practices is a Huntingdon Valley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ismp.org

  • Huntingdon Valley, PA USA 19006
  • Phone: 215.947.7797

Executives

Name Title Contact Details

Similar Companies

University of Connecticut Health Center

The UConn Health Center offers an impressive range of clinical services by more than 350 physicians in over 50 specialties on an outpatient basis and on an inpatient basis at John Dempsey Hospital.

Health One

Health One is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Virtual Radiologic Corporation

Virtual Radiologic Corporation is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Virtual Radiologic Corporation is based in Eden Prairie, MN. You can find more information on Virtual Radiologic Corporation at www.virtualrad.com

Family Care Spcalists Med Corp

Family Care Spcalists Med Corp is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Los Angeles, CA. To find more information about Family Care Spcalists Med Corp, please visit www.fcsmg.com

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.